Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants
Clinical trial NCT06820307 · COMPLETED
Trial details
- NCT number
- NCT06820307
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-25
- Primary completion
- 2025-04-29
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.